insights_auto
Bakit tumaas ang NOVOBN 5.67%?
Tingnan ang Higit pang Detalyechevron_right
NOVOBN:BMV
Novo Nordisk A/S
MX$764.50
arrow_upward
+5.67%(+41.00) 1D
Okt 16, 2:00:00 PM GMT-6 · MXN
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa NOVOBN...
Buksan
MX$728.00
Mataas
MX$764.50
Mababa
MX$728.00
Mkt. cap
132.00B
Avg. na dami
386.00
Dami
21.00
Mataas nang 52-wk
MX$1,149.99
Mababa nang 52-wk
MX$630.00
Bilang ng mga empleyado
67K
Buksan
MX$728.00
Mataas
MX$764.50
Mababa
MX$728.00
Mkt. cap
132.00B
Avg. na dami
386.00
Dami
21.00
Mataas nang 52-wk
MX$1,149.99
Mababa nang 52-wk
MX$630.00
Bilang ng mga empleyado
67K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
The Motley Fool
·
11 oras ang nakalipas
Novo Trades at Less Than 12 Times Earnings. Is This the Buying Opportunity of the Decade?
The Motley Fool
·
2 araw ang nakalipas
Novo Nordisk and Eli Lilly Just Got Some Fantastic News
Yahoo Finance
·
5 araw ang nakalipas
Top Analyst Reports for Walmart, Visa & Novo Nordisk
The New York Times
·
1 buwan ang nakalipas
Ozempic Jab’s Creator Needs a Second Act. Pills May Be the Answer.
Profile
Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. In 2023, Novo's market capitalization exceeded the GDP of Denmark, and it became the highest valued company in Europe. Wikipedia
Tungkol sa Novo Nordisk A/S
CEOMike Doustdar
Mga Empleyado66.7K
Itinatag1923
HeadquartersBagsværd, Capital Region of Denmark, Denmark
Sektor-
Websitenovonordisk.com